Alignment Healthcare, Inc. (ALHC) Stock Forecasts
Argus has issued a HOLD rating for Alignment Healthcare Inc (ALHC) with a target price of $8.00. The report details subratings for Industry (Medium), Management (Low), Safety (Low), Financial Strength (Low), Growth (Medium), and Value (Low). The article also lists related reports for other companies.
Q2 Earnings Highlights: Alignment Healthcare (NASDAQ:ALHC) Vs The Rest Of The Health Insurance Providers Stocks
This article analyzes the Q2 earnings performance of Alignment Healthcare (NASDAQ:ALHC) and compares it to other health insurance providers. While the health insurance sector saw strong Q2 revenues, share prices generally declined. Alignment Healthcare exceeded revenue and EPS expectations but saw its stock drop significantly, while CVS Health also had a strong quarter but experienced a stock decline.
Q2 Earnings Highlights: Alignment Healthcare (NASDAQ:ALHC) Vs The Rest Of The Health Insurance Providers Stocks
This article analyzes the Q2 earnings performance of Alignment Healthcare (NASDAQ:ALHC) and compares it to other health insurance providers. While the overall sector showed strong Q2 results, many companies, including ALHC and CVS Health, experienced stock price declines despite beating revenue estimates. The article also touches on market risks like AI's long-term impact and geopolitical events, while highlighting top and weakest performers in the health insurance sector.
Are Options Traders Betting on a Big Move in Alignment Healthcare Stock?
Options traders are showing high implied volatility for Alignment Healthcare (ALHC), suggesting expectations of a significant price movement. Despite this, analysts have a negative outlook, with the company currently holding a Zacks Rank #4 (Sell) and recent downward revisions to earnings estimates. This discrepancy could indicate an opportunity for seasoned options traders to sell premium, betting that the stock won't move as much as implied volatility suggests.
ALHC ALERT: Hagens Berman Updates Investigation of
Hagens Berman is updating its investigation into Alignment Healthcare (NASDAQ: ALHC) after the company's stock collapsed nearly 20% following disclosures at an analyst conference. Management revealed additional unexpected investments and new headwinds related to escalating medical costs. This comes after a recent whistleblower complaint alleged financial misclassification and a disappointing Q2 earnings report.
Are Options Traders Betting on a Big Move in Alignment Healthcare Stock?
Options traders are showing increased interest in Alignment Healthcare (ALHC) with high implied volatility for its January 2027 $22.50 Call options, suggesting expectations of a significant price movement. Despite this, the company currently holds a Zacks Rank #4 (Sell), with analysts lowering earnings estimates. This discrepancy between options market activity and analyst sentiment might indicate a potential trading opportunity for those looking to sell premium.
Nearly 9.5 million Medicare-eligible seniors live in counties where Alignment Health will offer 2027 plans.
Alignment Health (ALHC) is expanding its Medicare Advantage service area in 2027 by adding 10 new counties across Arizona, California, Nevada, North Carolina, and Texas, bringing its total footprint to 55 counties. This expansion will make Alignment Health plans accessible to nearly 9.5 million Medicare-eligible seniors. The company is also enhancing its provider networks, including access to Hoag in Orange County and Astrana Health in Southern California, and introducing new culturally connected plan options like Central Health Harmony for Asian American seniors.
Alignment Healthcare, Inc. (ALHC) options chain
This Yahoo Finance article provides detailed options chain data for Alignment Healthcare, Inc. (ALHC), including call and put options with various strike prices and expiration dates. The data, delayed by 15 minutes, shows the last trade date, last price, bid, ask, change, percentage change, volume, open interest, and implied volatility for each contract. The stock's current trading information and after-hours activity are also presented.
ALHC Stock Slides As Alignment Healthcare Reaffirms Guidance
Alignment Healthcare (NASDAQ: ALHC) stock has seen significant drops despite the company reaffirming its financial guidance. While there's bullish sentiment on Medicare Advantage growth and the company expanded its partnership with Hoag Health System, CEO share sales and recent price declines have negatively impacted investor sentiment. Analysts note the company's strong growth but thin profitability, suggesting a richly valued model with execution risk, and predict the stock will trade in a 7.50–9.00 range in the near term.
ALHC Drops Sharply As Alignment Healthcare Holds Guidance Steady
Alignment Healthcare (ALHC) shares dropped significantly despite the company reaffirming its guidance and management indicating only modest, transitory institutional cost pressures. The stock is showing signs of short-term recovery with tactical support forming. This suggests a sentiment dislocation rather than underlying business weakness, and an expanded partnership with Hoag Health System further strengthens its competitive position.
ALHC Stock Slides As Legal And Cost Pressures Mount
Alignment Healthcare Inc. (ALHC) stock has been declining due to concerns over Medicare Advantage reimbursement pressures, regulatory scrutiny, and rising medical costs. Shares plunged after management flagged unexpected second-half spending and a whistleblower alleged misclassification of expenses to inflate adjusted EBITDA. Multiple law firms are now investigating potential securities law violations and accounting issues, adding to the stock's volatility and downward pressure.
ALHC ALERT: Hagens Berman Updates Investigation of Alignment Healthcare (NASDAQ: ALHC) Following Baird Conference Disclosures
Hagens Berman has updated its investigation into Alignment Healthcare (NASDAQ: ALHC) following disclosures made at the Baird Global Healthcare Conference. The investigation focuses on whether ALHC and its executives provided misleading statements to investors, particularly regarding its ability to grow and manage medical costs for its Medicare Advantage plans.
ALHC ALERT: Hagens Berman Updates Investigation of Alignment Healthcare (NASDAQ: ALHC) Following Baird Conference Disclosures
Hagens Berman is updating its investigation into Alignment Healthcare (NASDAQ: ALHC) after the stock experienced a nearly 20% collapse following disclosures made by management at the Baird 2026 Global Healthcare Conference. These disclosures, coupled with previous whistleblower allegations of financial misreporting and a disappointing Q2 earnings report, have raised investor concerns. Hagens Berman is investigating whether the company misled the market and encourages affected investors to come forward.
Alignment Healthcare stock hits 52-week low at $8.25
Alignment Healthcare (ALHC) stock has fallen to a new 52-week low of $8.25, with a significant year-to-date loss of nearly 58% and a 35.5% decline in the last week. Despite this downturn, InvestingPro data suggests the stock may be undervalued, and the company recently surpassed Q2 2026 earnings expectations while raising full-year guidance. However, analyst ratings are mixed, with TD Cowen reiterating a Buy while Raymond James downgraded the stock due to earnings visibility concerns.
Tax-withholding share sale by Alignment Healthcare (ALHC) exec
Joseph S. Konowiecki, EVP of Corporate Affairs at Alignment Healthcare (ALHC), sold 23,511 shares of common stock at a weighted-average price of $8.61 per share on September 17, 2026. This sale was conducted to cover tax withholding obligations arising from restricted stock unit vesting and was not a discretionary trade. Following the transaction, Konowiecki retains direct ownership of 1,080,305 ALHC shares.
Alignment Healthcare EVP Joseph S. Konowiecki Sells 23,511 Shares to Meet Tax Withholding Requirements
Joseph S. Konowiecki, EVP of Corporate Affairs and Director at Alignment Healthcare, Inc. (NASDAQ:ALHC), sold 23,511 shares on September 17, 2026. This sale, at a weighted-average price of $8.61 per share, was executed solely to cover tax withholding obligations related to vested restricted stock units, not as a discretionary trade. Following the transaction, Konowiecki retains direct beneficial ownership of 1,080,305 shares.
ALHC Stock Slides As Legal And Cost Pressures Mount
Alignment Healthcare (ALHC) stock has significantly dropped due to concerns over Medicare Advantage reimbursement, regulatory pressures, and a whistleblower complaint alleging misclassification of expenses to inflate Adjusted EBITDA. Management's commentary on Q3 medical cost headwinds and increased second-half spending further contributed to the decline. Multiple law firms are now investigating the company for potential securities fraud, and insider selling has added to investor uncertainty.
Alignment Healthcare Insider Sold Shares Worth $356,200, According to a Recent SEC Filing
An insider at Alignment Healthcare recently sold shares valued at $356,200, as detailed in a recent SEC filing. This transaction follows other significant insider share sales at the company in recent weeks, indicating active insider trading. Alignment Healthcare, Inc. (ALHC) operates Medicare Advantage Plans and reported its Q2 2026 earnings with revenue increases and guidance for Q3 and full-year.
Alignment Healthcare Isn't On Triage, But It's Still Not Worth Buying
Alignment Healthcare (ALHC) is experiencing significant cost pressures despite growing revenue and membership. The company's valuation is considered fair, not cheap, compared to its peers. Management has maintained its 2026 guidance but noted elevated medical costs, leading to a reaffirmed 'hold' rating due to cost headwinds and limited valuation upside.
Is Alignment Healthcare (ALHC) Still About Right After Its 57% Slide?
Alignment Healthcare (ALHC) has experienced a significant 57% slide in its share price this year, prompting investors to scrutinize its market valuation against its earnings potential. Despite legislative changes potentially impacting Medicare Advantage margins, the company's P/E ratio of 44.4x, though higher than sector and peer averages, is considered "about right" by a fair-multiple model, suggesting the market has already factored in these risks. The article explores whether the current stock price aligns with its current and future earnings, highlighting an analyst narrative that suggests it could be significantly undervalued.
Rosen Law Firm Encourages Alignment Healthcare, Inc. Investors to Inquire About Securities Class Action Investigation - ALHC
The Rosen Law Firm has initiated an investigation into potential securities claims against Alignment Healthcare, Inc. (NASDAQ: ALHC) following allegations of misleading business information. This investigation comes after a SeekingAlpha article reported a significant stock drop due to disclosed additional investments and emerging medical cost headwinds. Investors who purchased ALHC securities are encouraged to contact the firm to potentially recover losses through a class action lawsuit.
Astrana Health, Clover Health, Alignment Healthcare, and Novavax Stocks Trade Down, What You Need To Know
Stocks for Astrana Health, Clover Health, Alignment Healthcare, and Novavax traded down after bipartisan lawmakers introduced the Protecting Approved Care Act. This legislation aims to reform prior authorization and payment rules in Medicare Advantage plans, potentially impacting health insurers' operating margins by limiting their ability to retroactively deny reimbursements. Alignment Healthcare experienced a significant 12.6% drop, with its shares trading 58% below its 52-week high.
Alignment Healthcare extends retreat, falls an additional 16% (ALHC:NASDAQ)
Alignment Healthcare (ALHC) shares dropped 16% on Wednesday, extending a 20% selloff from the previous session, after management's comments at the Baird 2026 Global Healthcare Conference. The company highlighted additional planned investment and emerging medical-cost pressures, leading to a new 52-week low for the stock. Despite a recent analyst upgrade, volatility is expected to continue due to investor concerns about these cost pressures.
ALHC Stock Tumbles After ‘Don’t Poke the Bear’ Silence On Star Ratings — CLOV Falls With It
Alignment Healthcare (ALHC) shares fell 22% after executives at a Baird conference refused to discuss next year's Medicare Advantage star ratings and acknowledged higher-than-expected hospital costs. CEO John Kao cited CMS sensitivity for the silence on star ratings, while CFO Jim Head highlighted ongoing issues with institutional spending. The company attributed recent challenges to a system overhaul, though retail investor sentiment for both ALHC and Clover Health (CLOV) has risen.
Alignment Healthcare Insider Sold Shares Worth $7,121,671, According to a Recent SEC Filing
An insider at Alignment Healthcare (ALHC) recently sold shares totaling $7,121,671, as disclosed in a recent SEC filing. This significant transaction provides insight into insider activity for the healthcare company.
Alignment Healthcare (NASDAQ: ALHC) director plans tax-cover sale of 26,000 shares
Alignment Healthcare (ALHC) director and EVP Joseph Konowiecki has filed a Rule 144 notice to sell 26,000 shares of common stock, valued at $226,460, primarily to cover tax obligations on vested restricted stock units. This sale, expected around September 17, 2026, is not a discretionary trade but a "sale-to-cover" transaction. The filing also reveals previous sales under a 10b5-1 plan totaling 75,000 shares for approximately $1.73 million within the last three months.
Alignment Healthcare (ALHC) trust plans $6.5M sale of pre-IPO shares
A trust associated with Alignment Healthcare (ALHC) plans to sell 500,000 pre-IPO common shares under Rule 144, valued at approximately $6.5 million. The shares were originally issued in exchange for partnership units. The filing also reports two prior sales of 298,000 shares each in July and August 2026, totaling over $10 million, all conducted through a 10b5-1 sales plan with Morgan Stanley Smith Barney LLC.
Alignment healthcare CEO John Kao sells $7.1m in stock
John E. Kao, CEO of Alignment Healthcare (NASDAQ:ALHC), sold a total of 557,870 shares for approximately $7.12 million in September 2026. One sale was part of a Rule 10b5-1 trading plan, while the other was to cover tax withholding obligations on restricted stock units. These transactions occurred as the company's stock traded near its 52-week low, although an InvestingPro analysis suggests it may be undervalued.
Alignment healthcare president Dawn Maroney sells $1.55m in stock By Investing.com
Dawn Maroney, President of Alignment Healthcare, sold 122,707 shares of company stock worth approximately $1.55 million. These mandatory sales covered tax withholding obligations related to restricted stock unit vesting, not discretionary trading. The stock is currently trading near its 52-week low, but InvestingPro analysis suggests it may be undervalued.
Alignment healthcare president Dawn Maroney sells $1.55m in stock
Dawn Maroney, President of Alignment Healthcare, Inc. (NASDAQ:ALHC), sold 122,707 shares of company stock worth $1.55 million on September 11, 2026. These sales were mandatory to cover tax withholding obligations related to restricted stock unit vesting. The transactions occurred amid challenging market conditions for Alignment Healthcare, with the stock trading near its 52-week low despite recent positive earnings reports.
Alignment Health’s Fifth Annual Survey Finds Seniors Falling Further Behind: Aging in Place Challenges Continue to Rise as Support Gaps Widen
Alignment Health's fifth annual survey reveals that 90% of seniors face at least one social barrier affecting their health, independence, or access to care, with aging-in-place challenges, healthcare access, and economic instability being the top three threats. The study highlights worsening conditions from 2025 to 2026, including increases in aging-in-place difficulties and support gaps, leading over a quarter of seniors to skip necessary medical care. Seniors are increasingly seeking support services beyond traditional healthcare, with strong interest in personalized wellness recommendations, 24/7 doctor access, and financial assistance for groceries and utilities.
Alignment Health’s Fifth Annual Survey Finds Seniors Falling Further Behind: Aging in Place Challenges Continue to Rise as Support Gaps Widen
Alignment Health's fifth annual "Social Threats to Aging Well in America" survey reveals that 90% of seniors face at least one factor affecting their health or independence, with challenges like aging in place, support gaps, and medical
Alignment Healthcare (ALHC) CEO plans stock sale to cover taxes
Alignment Healthcare CEO John Kao has filed a Rule 144 notice to sell up to 405,000 shares of ALHC common stock. This sale is a "sale-to-cover" transaction, intended to cover tax withholding obligations tied to vested equity awards, rather than a discretionary trade. The actual number of shares sold will depend on tax rates and the stock price at the time of sale.
Alignment Health’s Fifth Annual Survey Finds Seniors Falling Further Behind: Aging in Place Challenges Continue to Rise as Support Gaps Widen
Alignment Health's fifth annual "Social Threats to Aging Well in America" survey reveals that 90% of seniors face at least one barrier to health, independence, or care access, with key indicators like aging in place challenges and support gaps worsening in 2026. The study, conducted with Ipsos, highlights increasing economic instability and healthcare access issues, leading over a quarter of seniors to skip needed medical care. Seniors are expressing strong interest in health plan benefits that address social needs beyond traditional medical care.
Alignment Healthcare (ALHC): Buy, Sell, or Hold Post Q2 Earnings?
Alignment Healthcare's stock price has dropped by 27.6% over the last six months. The article analyzes ALHC's strong momentum through skyrocketing revenue, outstanding long-term EPS growth, and increasing free cash flow margin, suggesting it could be an opportune time to consider buying despite the recent downturn. It encourages readers to consult a full research report for a comprehensive decision.
Alignment Healthcare (ALHC) Stock Drops 16.7% After Whistleblower Alleges Accounting Irregularities; Law Firm Launches Investigation
Alignment Healthcare (NASDAQ: ALHC) saw its stock drop 16.7% after a whistleblower complaint alleged accounting irregularities, including the systematic misclassification of operating expenses as capital expenditures. The complaint, filed by a former executive, claims the company artificially inflated its financial results, particularly its Adjusted EBITDA, which is tied to executive compensation. New York-based law firm Kaplan Fox & Kilsheimer LLP has launched an investigation into potential securities law violations, assessing whether investors suffered losses due to misleading financial disclosures.
Kaplan Fox Announces an Investigation Into Alignment Healthcare, Inc. (NASDAQ: ALHC) for Potential Securities Law Violations
Kaplan Fox & Kilsheimer LLP is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for potential securities law violations after a whistleblower alleged "accounting irregularities" artificially inflated the company's financial results. The complaint claims operating expenses were misclassified as capital expenditures. Following this news on July 8, 2026, Alignment Healthcare's stock price dropped by 16.7%.
Kaplan Fox Investor Alert: Alignment Healthcare, Inc. (NASDAQ: ALHC) Investigated for Potential Securities Law Violations
Kaplan Fox & Kilsheimer LLP is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for potential securities law violations after a whistleblower alleged "accounting irregularities." The complaint claims that millions in operating expenses were misclassified as capital expenditures, artificially inflating the Company's financial results and a key metric for executive compensation. Following this news, Alignment Healthcare's stock price dropped by 16.7%.
Kaplan Fox is Investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for Investors Who Acquired the Company s Securities
Kaplan Fox & Kilsheimer LLP is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) following a whistleblower complaint alleging accounting irregularities and inflated financial results. The complaint claims operating expenses were misclassified as capital expenditures, leading to a significant stock price drop on July 8, 2026. Investors who suffered losses are encouraged to contact Kaplan Fox for more information.
Kaplan Fox Launches Investigation into Alignment Healthcare (ALHC) Following Whistleblower Allegations of Accounting Misconduct
Kaplan Fox & Kilsheimer LLP has initiated an investigation into Alignment Healthcare (NASDAQ:ALHC) following whistleblower allegations of accounting misconduct. A former executive claims the company misclassified operating expenses as capital expenditures to inflate financial metrics. This led to a 16.7% stock drop for ALHC on July 8, 2026, prompting the law firm to seek investors affected by these losses.
Kaplan Fox Investigates Alignment Healthcare (ALHC) Over Alleged Accounting Irregularities and Whistleblower Claims
Law firm Kaplan Fox & Kilsheimer LLP is investigating Alignment Healthcare (NASDAQ: ALHC) following a whistleblower complaint alleging systematic misclassification of operating expenses as capital expenditures. This alleged practice artificially inflated key financial metrics like Adjusted EBITDA. The news caused ALHC shares to drop 16.7% on July 8, 2026, and the firm is now inviting investors who suffered losses to contact them regarding potential securities violations.
Kaplan Fox Reminds Investors of Alignment Healthcare, Inc. (NASDAQ: ALHC) to Protect Their Rights Amid a Securities Investigation
Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. (NASDAQ: ALHC) following allegations of accounting irregularities that artificially inflated the company's financial results. A whistleblower complaint claims that millions in operating expenses were misclassified as capital expenditures. Following this news on July 8, 2026, Alignment Healthcare's stock price dropped significantly.
Kaplan Fox Reminds Investors of Alignment Healthcare, Inc. (NASDAQ: ALHC) to Protect Their Rights Amid a Securities Investigation
Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. (NASDAQ: ALHC) following a whistleblower complaint. The complaint alleges "accounting irregularities" and the artificial inflation of the company's financial results, specifically Adjusted EBITDA, by misclassifying operating expenses as capital expenditures. This news led to a significant drop in Alignment Healthcare's stock price.
Alignment Healthcare (ALHC) Stock Drops 16.7% After Whistleblower Alleges Accounting Irregularities
Alignment Healthcare (NASDAQ: ALHC) saw its stock drop 16.7% after a whistleblower complaint alleged accounting irregularities that artificially inflated the company's financial results by misclassifying operating expenses as capital expenditures. Law firm Kaplan Fox & Kilsheimer LLP is investigating potential securities violations, and investors who suffered losses are encouraged to contact the firm. The complaint specifically targets the company's Adjusted EBITDA, a key non-GAAP metric.
ALHC | Alignment Healthcare, Inc. Common Financials - Revenue Breakdown
This article provides a financial overview of Alignment Healthcare, Inc. (ALHC), including its revenue breakdown, insider trading activity, institutional ownership, and corporate lobbying efforts. It highlights the company's business model as a next-generation healthcare platform for seniors through Medicare Advantage plans. The page also offers various financial tools and data points for investors, such as analyst ratings, price targets, and a proprietary Smart Score.
Kaplan Fox Encourages Alignment Healthcare, Inc. (NASDAQ: ALHC) Investors to Learn More About Their Legal Rights
Kaplan Fox & Kilsheimer LLP is investigating potential securities violations by Alignment Healthcare, Inc. (NASDAQ: ALHC) following allegations from a former executive. A whistleblower complaint claims the company engaged in "accounting irregularities" by misclassifying millions of dollars in operating expenses as capital expenditures, which allegedly inflated financial results, including Adjusted EBITDA. This news led to a significant 16.7% drop in Alignment Healthcare's stock price on July 8, 2026.
Kaplan Fox Encourages Alignment Healthcare, Inc. (NASDAQ: ALHC) Investors to Learn More About Their Legal Rights
Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. after a whistleblower complaint alleged "accounting irregularities" that artificially inflated the company's financial results. This news led to a significant drop in Alignment Healthcare's stock price. The law firm is encouraging investors who have suffered losses to contact them for more information regarding their legal rights.
Alignment Healthcare to Present in Baird 2026 Global Healthcare Conference and Attend Morgan Stanley 24th Annual Global Healthcare Conference
Alignment Healthcare, Inc. (NASDAQ: ALHC) announced its participation in two upcoming healthcare conferences in New York. The company will present a fireside chat at the Baird 2026 Global Healthcare Conference on September 15th and attend the Morgan Stanley 24th Annual Global Healthcare Conference on September 16th. A webcast of the Baird presentation will be available on Alignment's investor relations website.
Alignment Healthcare has two New York conference appearances scheduled for September
Alignment Healthcare (NASDAQ: ALHC) announced its participation in two upcoming healthcare conferences in New York. The company will present at the Baird 2026 Global Healthcare Conference with a fireside chat and presentation on September 15th, and will attend the Morgan Stanley 24th Annual Global Healthcare Conference on September 16th. A webcast of the Baird presentation will be available on Alignment's investor relations website.
Kaplan Fox Notifies Investors of Alignment Healthcare, Inc. (NASDAQ: ALHC) of a Pending Securities Investigation
Kaplan Fox & Kilsheimer LLP is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for potential securities violations. This investigation follows a whistleblower complaint alleging accounting irregularities and artificial inflation of financial results, including Adjusted EBITDA, which led to a significant stock price drop on July 8, 2026. Investors who suffered losses are encouraged to contact Kaplan Fox for more information.
